VanEck Pharmaceutical ETF (PPH) ist ein börsennotiertes Unternehmen im Finanzdienstleistungen Sektor, tätig in der Asset Management Branche.
PPH hat IPO-Datum 2000-02-01, gelistet an der NASDAQ Global Market, eine Marktkapitalisierung von $610.23M.
VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
